John Maroney

John Maroney is CEO of ForSight VISION5. John was a full-time member of the Delphi Ventures investment team for over ten years, where he focused on early stage medical device investments and continues his board of directors relationship with one of the Delphi Ventures portfolio companies. Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. in 2007. From 1988 to 1997, John held a variety of senior management positions including President and General Manager at EP Technologies, Vice President of Operations at both Boston Scientific Corporation and Cardiovascular Imaging Systems (CVIS). While at CVIS, John was a key member of the senior management team during the Company’s IPO and eventual acquisition by Boston Scientific Corporation.